The EPSRC and MRC Systems Approaches to Biomedical Science CDT is an innovative 4-year D.Phil. programme in which every student works in collaboration with industry, conducting cutting edge research in:
- Computational and structural approaches underpinning drug and therapy discovery
- Data-driven drug discovery
- Physiological modelling underpinning drug discovery
We are an open collaboration between Oxford and 16 partner organisations (currently AstraZeneca, Diamond Light Source, e-Therapeutics, Evotec, GE Healthcare, GlaxoSmithKline, Hoffmann La Roche, InhibOx, Lilly UK, MedImmune, Moffitt Cancer Center, Novartis, Pfizer, Sharp, Structural Genomics Consortium and UCB, and we also have students working on projects with Microsoft and Silver Creek).
We encourage applications from students with a wide range of academic backgrounds, including Mathematics, Computing, Statistics, Chemistry, Biochemistry, Physics, Biology, Pharmacology and Engineering. Fully funded studentships for home and EU students are now available. Although the CDT cannot provide funding for Overseas students, there are a number of scholarship opportunities you can be considered for separately if you apply to the programme by 22 January 2016, please see http://www.ox.ac.uk/admissions/graduate/fees-and-funding for details.
Please explore the links on this website to find more information about the programme and the research training provided, as well as funding available and instructions on how to apply.
The Doctoral Training Centre is a member of the Graduate Academic Programme (GAP) and fully supports the teaching and training of graduate students across the University of Oxford.
Although the programme is still accepting applications for entry in 2016-17, please be aware that the majority of places for this programme have now been filled and only exceptional candidates will be considered at this stage.
Note: In Oxford, the degree qualification commonly referred to as a Doctorate of Philosophy or Ph.D. is known as a D.Phil.